Clinical Trial Update: Efficacy Study of Chinese Medicine Plus EGFR-TKI Versus EGFR-TKI in Advanced Pulmonary Adenocarcinoma

View source ↗

Summary

Clinical trial evaluating whether adding Chinese herbal medicine to EGFR-TKI improves outcomes in advanced non-small cell lung cancer, compared to EGFR-TKI alon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Chinese medicine (herbal therapy) (herbal medicine)
• EGFR-TKI (EGFR tyrosine kinase inhibitor)

Snippet

Sponsor: Shanghai University of Traditional Chinese Medicine | Conditions: Cancer | Status: UNKNOWN